Keros Therapeutics (KROS) Interest Expenses (2019 - 2022)
Keros Therapeutics (KROS) reported Interest Expenses of $1000.0 for Q1 2022, little changed on a YoY basis from $1000.0 in Q1 2021, and little changed quarter-over-quarter from $1000.0 in Q4 2021.
Keros Therapeutics (KROS) Interest Expenses (2019 - 2022) Analysis & Trends
Keros Therapeutics has reported Interest Expenses for 4 years, with the latest figure at $1000.0 in Q1 2022.
- For the quarter ending Q1 2022, Interest Expenses changed 0.0% year-over-year to $1000.0; the trailing twelve-month figure through Dec 2022 stood at $1000.0 (down 75.0% YoY), and the FY2022 full-year result was $1000.0, down 75.0% from the prior year.
- Interest Expenses for Q1 2022 stood at $1000.0, roughly flat from $1000.0 in the prior quarter.
- The five-year high for Interest Expenses was $3000.0 in Q3 2019, with the low at $1000.0 in Q2 2020.
- Historically, Interest Expenses has averaged $1500.0 across 4 years, with a median of $1000.0 in 2020.
- The largest YoY upside for Interest Expenses was 0.0% in 2020 against a maximum downside of 50.0% in 2020.
- Keros Therapeutics' Interest Expenses stood at $3000.0 in 2019, then slumped by 66.67% to $1000.0 in 2020, then changed by 0.0% to $1000.0 in 2021, then changed by 0.0% to $1000.0 in 2022.
- The last three Interest Expenses figures came in at $1000.0 (Q1 2022), $1000.0 (Q4 2021), and $1000.0 (Q3 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 61,000.00 |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | -332,000.00 |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | - |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -5.58 Mn |
| 10 | Keros Therapeutics | 378.54 Mn | 91.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 1,000.00 |
| Mar 31, 2022 | 1,000.00 |
| Dec 31, 2021 | 1,000.00 |
| Dec 31, 2021 | 1,000.00 |
| Sep 30, 2021 | 1,000.00 |
| Sep 30, 2021 | 1,000.00 |
| Jun 30, 2021 | 1,000.00 |
| Jun 30, 2021 | 1,000.00 |
| Mar 31, 2021 | 1,000.00 |
| Mar 31, 2021 | 1,000.00 |
| Dec 31, 2020 | 1,000.00 |
| Dec 31, 2020 | 1,000.00 |
| Sep 30, 2020 | 2,000.00 |
| Sep 30, 2020 | 2,000.00 |
| Jun 30, 2020 | 1,000.00 |
| Jun 30, 2020 | 1,000.00 |
| Mar 31, 2020 | 2,000.00 |
| Mar 31, 2020 | 2,000.00 |
| Sep 30, 2019 | 3,000.00 |
| Sep 30, 2019 | 3,000.00 |